Medpace Holdings Inc
NASDAQ:MEDP
Medpace Holdings Inc
Gross Profit
Medpace Holdings Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Medpace Holdings Inc
NASDAQ:MEDP
|
Gross Profit
$549.4m
|
CAGR 3-Years
23%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Gross Profit
$17.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
Danaher Corp
NYSE:DHR
|
Gross Profit
$25.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Gross Profit
$2.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Agilent Technologies Inc
NYSE:A
|
Gross Profit
$3.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Gross Profit
$5.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
See Also
What is Medpace Holdings Inc's Gross Profit?
Gross Profit
549.4m
USD
Based on the financial report for Mar 31, 2024, Medpace Holdings Inc's Gross Profit amounts to 549.4m USD.
What is Medpace Holdings Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
20%
Over the last year, the Gross Profit growth was 18%. The average annual Gross Profit growth rates for Medpace Holdings Inc have been 23% over the past three years , 20% over the past five years .